Vol 13, No 1 (2018)
Conference report / Report
Published online: 2018-03-23
Preventive cardiology in the aspect of recent reports from the Congress of the European Society of Cardiology in Barcelona, August 26–30, 2017
DOI: 10.5603/FC.2018.0018
Folia Cardiol 2018;13(1):101-103.
Abstract
< p > < /p >
Keywords: preventive cardiologyESC
References
- Eikelboom JW, Connolly SJ, Bosch J, et al. COMPASS investigators. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. N Engl J Med. 2017; 377(14): 1319–1330.
- Ridker PM. How Common Is Residual Inflammatory Risk? Circ Res. 2017; 120(4): 617–619.
- Ridker PM, Everett BM, Thuren T, et al. CANTOS Trial Group. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med. 2017; 377(12): 1119–1131.
- Bowman L, Hopewell JC, Chen F, et al. HPS3/TIMI55–REVEAL Collaborative Group. Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease. N Engl J Med. 2017; 377(13): 1217–1227.
- Dehghan M, Mente A, Zhang X, et al. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study. Lancet. 2017; 390(10107): 2050–2062.
